| Emcure Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 189.48 | 181.15 | 180.85 | 180.85 | 180.85 |
| Reserves | 2,834.88 | 1,753.95 | 1,661.02 | 1,531.68 | 2,120.92 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 3,024.36 | 1,935.10 | 1,841.87 | 1,712.53 | 2,301.77 |
| Secured Loans | 251.03 | 1,415.71 | 1,668.79 | 1,578.82 | 1,597.34 |
| Unsecured Loans | 606.38 | 179.74 | 103.84 | 0.00 | 67.18 |
| Total Debt | 857.41 | 1,595.45 | 1,772.63 | 1,578.82 | 1,664.52 |
| Other Liabilities | 56.07 | 62.35 | 52.04 | 134.49 | 45.15 |
| Total Liabilities | 3,937.84 | 3,592.90 | 3,666.54 | 3,425.84 | 4,011.44 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 3,183.30 | 2,952.69 | 2,472.14 | 2,031.30 | 2,013.34 |
| Less: Accumulated Depreciation | 1,424.24 | 1,234.45 | 1,039.44 | 879.82 | 735.44 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 1,759.06 | 1,718.24 | 1,432.70 | 1,151.48 | 1,277.90 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 99.11 | 106.40 | 253.10 | 239.25 | 192.09 |
| Investments | 677.65 | 684.00 | 690.02 | 563.36 | 863.73 |
| Current Assets, Loans & Advances | |||||
| Inventories | 1,038.18 | 770.27 | 709.93 | 730.44 | 621.77 |
| Sundry Debtors | 1,190.56 | 1,103.29 | 1,054.50 | 1,009.09 | 999.43 |
| Cash and Bank Balance | 13.80 | 32.12 | 141.02 | 47.88 | 260.73 |
| Loans and Advances | 217.50 | 217.75 | 234.06 | 354.21 | 333.53 |
| Total Current Assets | 2,460.05 | 2,123.43 | 2,139.50 | 2,141.63 | 2,215.46 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 1,352.52 | 1,090.56 | 879.42 | 808.62 | 745.68 |
| Provisions | 99.34 | 44.54 | 39.64 | 59.02 | 78.07 |
| Total CL & Provisions | 1,451.86 | 1,135.09 | 919.06 | 867.64 | 823.75 |
| Net Current Assets | 1,008.18 | 988.34 | 1,220.44 | 1,273.98 | 1,391.71 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 82.64 | 71.54 | 46.39 | 0.00 | 37.33 |
| Deferred Tax Liability | 109.04 | 100.48 | 76.63 | 29.70 | 65.34 |
| Net Deferred Tax | -26.40 | -28.94 | -30.24 | -29.70 | -28.01 |
| Other Assets | 420.24 | 124.85 | 100.52 | 227.47 | 314.01 |
| Total Assets | 3,937.84 | 3,592.89 | 3,666.54 | 3,425.84 | 4,011.43 |
| Contingent Liabilities | 234.04 | 162.14 | 2.08 | 4.34 | 5.06 |